BIFILAC CAPSULE 10'S

BIFILAC CAPSULE 10'S is a combination of probiotics that helps in restoring good bacteria in the gut.

It is used to treat conditions like diarrhea, antibiotic-associated diarrhea, inflammatory bowel disease, and other digestive disorders.

It contains probiotic strains like Lactobacillus, Bifidobacterium, and Streptococcus.

It is generally well-tolerated, but some people may experience gas or bloating.

Store it at room temperature, away from direct sunlight and heat.

Yes, but it's best to take it at least 2 hours after antibiotics so they don't kill the probiotics.

Consult a doctor before using it for children.

The dosage depends on the condition being treated. Always follow your doctor's instructions.

Consult a doctor before using during pregnancy.

Consult a doctor before using during breastfeeding.

It can be taken with or without food, but it's best to take it at the same time each day.

Take the missed dose as soon as you remember. If it's close to your next dose, skip the missed dose and continue with your regular schedule.

It may interact with other medications, especially antibiotics. Therefore, it's important to tell your doctor about any other medications you are taking.

Serious symptoms of an overdose of probiotics are rare, but some people may experience mild gastrointestinal distress.

Lactobacillus is one of the probiotic strains present in BIFILAC CAPSULE 10'S. BIFILAC includes other probiotic strains as well.

Bifilac is a probiotic preparation containing beneficial live microorganisms that help restore and maintain healthy intestinal flora. It is commonly used as supportive therapy in conditions such as antibiotic-associated diarrhea, infectious diarrhea (after appropriate treatment), traveler’s diarrhea, and nonspecific gastrointestinal discomfort like bloating or mild cramping. It may also be used as an adjunct in irritable bowel syndrome and other functional bowel disorders, as advised by a healthcare professional.

Bifilac works locally in the gastrointestinal tract. The probiotic strains colonize the gut and compete with harmful bacteria for nutrients and attachment sites on the intestinal lining. They produce substances such as lactic acid and other antimicrobial compounds that inhibit the growth of pathogenic organisms. In addition, they help strengthen the intestinal barrier and can modulate immune responses, which may reduce inflammation and improve overall gut function.

Bifilac can generally be taken with or without food, but many clinicians prefer administration with or shortly after meals to improve tolerance and potentially enhance survival of the probiotic organisms through the acidic environment of the stomach. Because specific instructions may vary by brand and formulation, patients should follow the directions on the product label or those provided by their healthcare professional.

Bifilac is often recommended as an adjunct to help reduce the risk of antibiotic-associated diarrhea by replenishing beneficial gut bacteria that may be disrupted by antibiotic therapy. Evidence suggests that certain probiotic strains can lower the incidence and severity of diarrhea in this context. However, it should not replace the prescribed antibiotic, and its use should be discussed with a healthcare professional, especially in high-risk or immunocompromised patients.

Bifilac and similar probiotic products are commonly used in children and are generally considered safe when used under appropriate medical guidance. They may be recommended in pediatric patients with diarrhea, after antibiotic courses, or in certain functional gastrointestinal disorders. However, dosing, duration, and suitability depend on the child’s age, weight, underlying health conditions, and the specific product formulation. Parents should consult a pediatrician before giving Bifilac to infants or young children.

Most people tolerate Bifilac well. The most commonly reported side effects are mild and transient, including increased gas, abdominal bloating, mild cramping, or soft stools, particularly during the first few days of use as the gut flora adjusts. Serious adverse events are rare but may include systemic infection in severely immunocompromised individuals or those with central venous catheters. Any persistent, severe, or unusual symptoms should prompt medical review.

Probiotics like those in Bifilac are generally considered to have a favorable safety profile in pregnancy, and some guidelines allow their use when clinically indicated. However, robust controlled data in pregnant women are limited, and individual risk–benefit assessment is important. Pregnant women should not start Bifilac on their own and should consult their obstetrician or healthcare professional before using any probiotic supplement.

Bifilac has a low potential for systemic drug–drug interactions because its action is largely confined to the gut. However, concurrent use with systemic antibiotics can reduce the viability of the probiotic organisms. For this reason, it is often advised to separate the timing of Bifilac and antibiotic doses by several hours. Patients taking immunosuppressive therapy, chemotherapy, or with serious underlying illness should seek medical advice before using Bifilac, as the risk profile may differ.

The duration of Bifilac use depends on the indication and clinical response. For antibiotic-associated diarrhea or short-term gastrointestinal upset, it is often used for the duration of antibiotic therapy and a few days thereafter, as advised by a clinician. In chronic or recurrent conditions, a longer course may be recommended. Because evidence for very prolonged continuous use is variable, patients should periodically review the need for ongoing therapy with their healthcare professional.

Bifilac should be used with caution, or only under specialist supervision, in individuals who are severely immunocompromised (for example, those with advanced HIV infection, patients on intensive chemotherapy, or post-transplant patients), in those with short bowel syndrome, critical illness in intensive care, or the presence of central venous catheters. People with a history of severe allergies to probiotic components or excipients should avoid the product. Anyone with significant underlying disease should seek medical advice before starting Bifilac.

Some people use Bifilac to support general gut health and potentially modulate immune function, as a balanced intestinal microbiota is linked to aspects of immune regulation. However, Bifilac is not a substitute for vaccines, prescribed medications, or a healthy lifestyle, and evidence for broad immune-enhancing effects in otherwise healthy individuals is still evolving. It should be viewed as an adjunctive measure rather than a primary therapy for immune-related conditions.